Four, resmetirom confers significant advantages to patient cohorts who do not meet the indication of GLP-1 therapies, including individuals who have already attained weight reduction and populations not afflicted with diabetes
Short-term (up to 4 weeks) : Brighter skin tone, better hydration, and increased energy levels Medium-term (13 months) : Reduced hyperpigmentation, more even skin tone, improved immunity, and sharper mental focus Long-term (over 3 months) : More pronounced skin brightening, anti-ageing effects, and liver health support To maintain these outcomes, patients are encouraged to: Stay hydrated by drinking 810 glasses of water daily Follow a diet rich in antioxidant-packed foods Use a broad-spectrum sunscreen (SPF 30+) every day While the improvements can be impressive, they are not permanent
Results do vary between individuals, and treatment should be reviewed at 12 weeks if less than 5% weight loss has been achieved at the full 3 mg dose
Boys cannot undergo puberty without sufficient testosterone levels